Cosio Fernando G, Grande Joseph P, Wadei Hani, Larson Timothy S, Griffin Matthew D, Stegall Mark D
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic and Foundation, Rochester, Minnnesota, USA.
Am J Transplant. 2005 Oct;5(10):2464-72. doi: 10.1111/j.1600-6143.2005.01050.x.
Identifying factors that are predictive of allograft loss might be an important step toward prolonging kidney allograft survival. In this study we sought to determine the association between histologic changes on 1-year surveillance biopsies, changes in graft function and survival. This analysis included 292 adults, recipients of kidneys from living donors (69%) or deceased donors (31%), transplanted between 1998 and 2001 and followed up for 46 +/- 14 months. The primary end point was death-censored graft loss or a >50% reduction in GFR beyond 1 year. One-year biopsies were classified as: (i) Normal (N = 87, 30%), (ii) inflammation (N = 6, 2%), (iii) fibrosis (N = 131, 45%), (iv) fibrosis and inflammation (N = 53, 18%) and (v) transplant glomerulopathy (N = 15, 5%). By multivariate Cox analysis, survival related to biopsy classification (HR = 4.2, p = 0.001), graft function (HR = 0.97, p = 0.001) and HLA mismatches (HR = 1.003, p = 0.004). Using normal histology as a reference, fibrosis and inflammation (HR = 8.5, p < 0.0001) and glomerulopathy (HR = 10, p < 0.0001) related to poorer survival but mild fibrosis alone did not. Importantly, the degree of inflammation associated with fibrosis generally did not qualify for the diagnosis of borderline rejection. In conclusion, inflammation and glomerulopathy 1 year post-transplant predict loss of graft function and graft failure independently of function and other variables.
识别预测移植肾失功的因素可能是延长肾移植存活时间的重要一步。在本研究中,我们试图确定1年监测活检的组织学变化、移植肾功能变化与存活之间的关联。该分析纳入了292例成年人,他们均为1998年至2001年间接受活体供肾(69%)或尸体供肾(31%)移植的受者,并随访了46±14个月。主要终点是死亡删失的移植肾失功或1年后肾小球滤过率降低>50%。1年活检结果分为:(i)正常(N = 87,30%),(ii)炎症(N = 6,2%),(iii)纤维化(N = 131,45%),(iv)纤维化伴炎症(N = 53,18%)和(v)移植性肾小球病(N = 15,5%)。通过多因素Cox分析,存活与活检分类(HR = 4.2,p = 0.001)、移植肾功能(HR = 0.97,p = 0.001)和HLA错配(HR = 1.003,p = 0.004)相关。以正常组织学为参照,纤维化伴炎症(HR = 8.5,p < 0.0001)和肾小球病(HR = 10,p < 0.0001)与较差的存活相关,但单独的轻度纤维化则不然。重要的是,与纤维化相关的炎症程度一般不符合临界排斥的诊断标准。总之,移植后1年的炎症和肾小球病可独立于功能及其他变量预测移植肾功能丧失和移植肾失败。